What data are collected? How, and who by?. It’s complicated… ONS data.

Slides:



Advertisements
Similar presentations
Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.
Advertisements

Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September How useful is the Cancer Waiting Times (CWT) dataset.
National Prostate Cancer Audit Julie Nossiter, Project Manager Clinical Effectiveness Unit – Royal College of Surgeons.
NPCA data submission and reporting
National Prostate Cancer Audit Heather Payne, NPCA Oncological Clinical Lead Consultant Clinical Oncologist, UCL.
Chameleon Information Management Services Ltd NPCA Update from InfoFlex Sarah Waters Director of New Business.
National Oesophago–Gastric Cancer Audit Comparing local and national figures.
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Taxanes for Ovarian Cancer: Progress Report Rosemary Tate Information Projects Team December 2000.
Computerised reporting and terminology John Williams BSG Endoscopy Section Symposium 19 March 2002.
The LCA: Implementing a Quality Assurance and Informatics Strategy to Enhance Cancer Care Dr Shelley Dolan LCA Clinical Director.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
National COPD Programme Building QI into Your Audit from the Start Prof. Mike Roberts Royal College of Physicians Barts Health/ UCLPartners On behalf of.
Mental Health Collaborative PAYMENT BY RESULTS BRIEF UPDATE.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
The National Mastectomy and Breast Reconstruction Audit Key findings of the Third Annual Report Slides produced by the MBR Project Team. © The National.
National Bowel Cancer Audit Clinical Audit Platform How to Register, Submit and View Reports CAP:
Survivorship Update January 2015 The Royal Wolverhampton NHS Trust James Owen Senior Cancer Services Manager.
Increasing awareness and early diagnosis of cancer An update from Primary Care Jo Preston Service Improvement Facilitator NECN Dr Bill Hall Primary Care.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
National Oesophago-Gastric Cancer Audit Clinical Audit Platform How to Register, Submit and View Reports CAP: |
Public Health England: opportunities for better coverage? Professor John Newton, Chief Knowledge Officer, Public Health England.
Calculating Quality Reporting Service – an introduction Chris Brown CQRS Design, Build and Test Project Manager 05 September 2012.
The National Renal Dataset Charlie Tomson UKRR Annual Meeting 24 th June 2009.
The Health Roundtable Improving data collection rates, while improving quality Presenter: Sandra Avery Liverpool Innovation Poster Session HRT1215 – Innovation.
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
BETTER CANCER CARE A Discussion Elizabeth Porterfield Head, NHS National Planning Team SGHD.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
National Cancer Intelligence Network data usage 17 November 2015 – Veronique Poirier – Principal Cancer Analyst – NCIN.
Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.
LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.
Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist,
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
What data are available, and how are they accessed?
How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.
National Cancer Intelligence Network What data are available, and how are they accessed? Cancer Roadshow (London) 13 th April 2015 Vivian Mak, Information.
Cancer Outcomes and Services Dataset What is COSD? Implications for Providers and Networks.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
What data are collected? How, and who by? Karen Graham and Barry Plewa.
NCIN Roadshow: Cancer Data NCIN - Cancer Data Roadshow Public Health England | 2015 Elsita Payne Head of Registration – East Midlands and North West Branches.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
Training for organisations participating in Peer Review of Paediatric Diabetes.
What does the cancer intelligence landscape look like now? Dr Mick Peake Clinical Lead, National Cancer Intelligence Network.
Systemic Anti Cancer Therapy (SACT) Monthly Update June 2015.
What data are available, and how are they accessed?
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
RECTAL CARCINOMA AND PREOPERATIVE MRI: USING A NATIONAL DATASET FOR REGIONAL AUDIT South West Cancer Intelligence Service J Weeks
Introduction to Hospital Episode Statistics (HES) Robel Feleke Knowledge and Intelligence Team (London) 20 th February 2014.
Cheshire and Merseyside Strategic Clinical Networks Local Issues and Challenges 22 nd May 2015.
The Quality Surveillance Team / Programme
Oesophago–Gastric Cancer Audit
National Bowel Cancer Audit
HANA A Head & Neck dataset for 2016
Oesophago–Gastric Cancer
National Oesophago–Gastric Cancer Audit 2015.
Systemic Anti Cancer Therapy (SACT) Cancer 52 Ralphael Oghagbon
Oesophago–Gastric Cancer
Oesophago–Gastric Cancer Audit
Oesophago–Gastric Cancer
National Lung Cancer Audit
Somerset Cancer Register
Somerset Cancer Register
Hannah Marder Cancer Manager UH Bristol
Somerset Cancer Register
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
2018 National Mesothelioma Audit
Quality Surveillance Programme
Breast Cancer SSG 14th November
Presentation transcript:

What data are collected? How, and who by?

It’s complicated… ONS data

Focus on the main data collections by trusts Two main types Cancer Information Standards National Cancer Audits Five standards and four audits (at present) Standards - mandated through NHS National contract and commissioning National audits - monitored through CQC and Quality Surveillance Programme (formerly Peer Review) Two main collection routes for cancer data from trusts PHE/NCRS HSCIC/CASU Other routine data and data collections such as HES and ONS deaths HSCIC collects most of the NHS data (including some cancer data) PHE/NCRS collates all cancer related data (some directly, some indirectly) 3

National audits Partnerships between clinical (Royal Colleges) and information services Four audits NBCA(NBOCAP) – Bowel NOGCA – Oesophago-gastric NLCA – Lung NPCA – Prostate DAHNO – Head & Neck currently no contract Breast Cancer - likely to be commissioned in 2015 Majority of audit data is also collected through COSD Try to upload monthly for audits as well as COSD Record in one place only for both COSD and audits 4

National Bowel Cancer Audit (NBCA)  Data submitted by all participating NHS Trusts / Hospitals (MDTs)  Case ascertainment in England: 94% (compared to HES)  Data completeness: 87% patients undergoing major surgery  Length of stay: large variation across SCNs (55% - 80% still in hospital 5 days after resection)  90 day post-operative mortality has fallen to 4.6% after major surgery  Overall 2 year survival: large variation across SCNs  Audit data used for Consultant Outcomes Publication 5

National Audits Consultant Outcomes Publications based on audit data COSD provides the routine data (Bowel audit only 4 additional items, lung all in COSD inc EGFR and smoking status) Good case ascertainment in established audits ( eg 94% Bowel) Developing PROMS/PREMS Increasing focus on using the data rather than collecting the data 6

NBCA - New contract 2015 – 18  Use redesigned minimum dataset (37 COSD and 4 audit-specific items)  Extend scope:  Look earlier in pathway Stage at diagnosis Where and how diagnosed  Audit of patients who do not have major resection Too frail Too little cancer Too much cancer  Look later in pathway Interventions Recurrence Long-term survival Further develop use of linked data (e.g. radiotherapy, chemotherapy, emergency laparotomy, intensive care) Establish feasibility of using information reported by patients 7

National Oesophago-gastric Cancer Audit (NOGCA)  Data submitted by all participating NHS trusts / hospitals (MDTs)  Case ascertainment: 80% tumour records / 95% surgical records  Linked to RTDS: 90.6% of radiotherapy records linked successfully  Over 1000 HGD cases submitted  Contract until June 2017 Audit data used for Consultant Outcomes Publication 8

Fall in both 30 and 90 day mortality post curative oesophagectomy and gastrectomy NOGCA Surgical Outcomes Oesophagectomy (%)Gastrectomy (%) Day mortality Day mortality Oesophagectomy (%)Gastrectomy (%) Day mortality Day mortality

National Prostate Cancer Audit Follows New model for national cancer audits Partnership between NCRS and professional bodies Based on COSD dataset routine collection Plus ~20 additional data items Data linkage by NCRS for analytical uses More timely collection and feedback Monthly submissions of data Regular feedback to clinical teams All audit reports on CancerStats – one site for cancer reports 10

National Lung Cancer Audit (NLCA)  Now uses COSD as its primary data source  This includes two new items - smoking status and EGFR status  Feedback on completeness to trusts May 2015  Annual Report December 2015  PROMS/PREMS element in development  Further information from: 11

Data Standards Five standards: CWT - Cancer Waits RTDS – Radiotherapy SACT – Chemotherapy DID – Diagnostic imaging COSD – Cancer Outcomes and Services COSD incorporates key audit fields and CWT fields 12

Cancer Waiting Times (CWT) – what’s new? Guidance document being updated  Cancer Waiting Times: a Guide Version 9 in progress  New data items to be collected from March 2016  NHS NUMBER STATUS INDICATOR CODE  REFERRAL REQUEST RECEIVED DATE (INTER-PROVIDER TRANSFER).  Change of submission type from March 2016  CSV replaced by XML submissions 13

Radiotherapy dataset (RTDS)  Previously collected and compiled by NatCanSAT (National Clinical Analysis and Specialised Applications Team)  Radiotherapy data will be collected and compiled by NCRS from April 2016  Exploring whether Commissioning data can be omitted as available forom other sources - ?just the key radiotherapy data items 14

Diagnostic Imaging Dataset (DID)  Record-level data from NHS Radiology Information Systems (RIS) in England Covers pathway – who, what, where, when etc But not reports  Now three years data and ready to link and assess impact of diagnostiic imaging on cancer outcomes  NHS staff can apply for access to the DID summary data  Further details:  Monthly provisional summary and annual reports by NHS England 

DID reports 16 NHS imaging activity in England by gender and age, Average period from date of test to date test report issued for Chest X- ray, by provider, Ultrasound activity by number of days from date of test request to date of test, by source of referral, 2013/14

Systemic Anti-Cancer Therapy (SACT) Monthly submissions from all trusts providing chemotherapy Currently to Chemotherapy Intelligence Unit in Oxford but moving into NCRS system Monthly, quarterly and annual reports available through website Coverage not yet complete for all trusts and cases Particularly haematology, paediatric and not hospital settings Some poorly collected data items eg Morphology, outcomes, performance status But new information never previously available 17

SACT – new information on chemotherapy March 14 to February 15 April 14 to March 15 Patients Receiving Drug Treatments 165,256165,883 Regimens Commenced282,646283,384 Cycles Commenced790,868805,326

SACT - Quality and completeness reports 19 Data completeness by diagnostic group Data completeness Trust Profile Data Quality Trust Profile

Cancer Outcomes and Services Dataset (COSD) – a reminder  Aligned and rationalised with other cancer datasets  Core subset incorporates registration data for national and international epidemiology etc  12 site specific subsets include key audit items for service and outcomes analysis etc  Include all recurrences and MDT meetings by July 2016  Pathology submissions in XML from January 2016 (structured data) – Plan by 1 st July 2015!  Key items:  Basis of diagnosis and morphology  Stage and performance status CNS contact Site specific audit items 20

How do we know it’s right? Clinicians are responsible for ensuring accurate data is recorded Make sure that you know how and when your data is submitted Agree a (manageable) system for checking accuracy Use the COSD portal regularly (ask for reports to be sent to you) 21

JAN FEBMAR APR MAYJUN JUL AUGSEPOCT NOV DEC NCRS Process Data NCRS JANUARY Data January: Level 3 Level 3 Report NCRS Reporting Portal Level 2 Report NCRS Reporting Portal Level 1 Report NCRS Reporting Portal COSD / Path PAS NHS Trust AUG

COSD portal – feedback reports 23

NHS TRUST HSCIC/CASU PHE/NCRS DID SACT CDS (HES) RTDS NOGCA (OG audit) NBCA (Bowel audit) COSD (HES) Procedures COSD (imaging) TestsReferral Diagnosis/PlanningTreatment COSD (MDT/ clinical) NLCA (Lung audit) NPCA (Prostate audit) COSD (Path) PAS RIS (imaging) LIMS (pathology) CANCER MANAGEMENT (MDT) E- prescribing Radiotherapy CWT

“Do once and share” Principle is to record once only on one system if possible Try to avoid transcribing from paper to electronic systems Try to use electronic systems where they are available CWT and most audit items are also included in COSD COSD submitted in multiple extracts from different systems (no need to duplicate entry) Try to avoid double entering data (eg audits can all be uploaded from local systems)

A burden shared… Most data is needed for clinical and/or patient pathway management Decide who is the best person to record the different data items Don’t leave it all to one person See who records the data items at the point of care Recording in MDT meetings can work – but needs to become routine 26

Thank you 27